What is Bridget Macaskill’s total JLL share ownership after this Form 4 transaction?

Following the June 1, 2026 grant, Bridget Macaskill directly holds 12,274 shares of JONES LANG LASALLE INC Common Stock. This total includes the newly granted 635-share award disclosed in the Form 4 insider trading report.

Director Bridget Macaskill receives 635 JLL (NYSE: JLL) shares in grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Macaskill Bridget reported acquisition or exercise transactions in this Form 4 filing.

JONES LANG LASALLE INC director Bridget Macaskill received a grant of 635 shares of Common Stock as compensation. The shares were granted on June 1, 2026 at a price of $0.00 per share, indicating they were an award rather than an open‑market purchase.

After this grant, Macaskill directly holds a total of 12,274 shares of JLL common stock. This filing records a routine equity award to a board member and does not reflect any open‑market buying or selling activity.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Macaskill Bridget

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	635	$0.00	--

Holdings After Transaction: Common Stock — 12,274 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares granted: 635 shares Grant price: $0.00 per share Total shares after grant: 12,274 shares

3 metrics

Shares granted 635 shares Common Stock grant on June 1, 2026

Grant price $0.00 per share Price for 635-share stock award

Total shares after grant 12,274 shares Direct ownership following June 1, 2026 grant

Key Terms

Common Stock, Grant, award, or other acquisition, reporting person

3 terms

Common Stock financial

"JONES LANG LASALLE INC Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction code description is "Grant, award, or other acquisition""

reporting person regulatory

"On June 1, 2026, the Reporting Person was granted 635 shares"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/01/2026 - 05:55 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Macaskill Bridget

(Last)

(First)

(Middle)

200 E. RANDOLPH DRIVE

(Street)

CHICAGO

ILLINOIS

60601

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JONES LANG LASALLE INC [ JLL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/01/2026		A⁽¹⁾		635	A	$0	12,274	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On June 1, 2026, the Reporting Person was granted 635 shares of common stock.

	/s/ Alan K.Tse, as attorney-in-fact for Bridget Macaskill	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did JLL director Bridget Macaskill report on this Form 4 for JLL?

Bridget Macaskill reported receiving a grant of 635 shares of JONES LANG LASALLE INC Common Stock. The award was made on June 1, 2026 at a price of $0.00 per share, reflecting a compensation-related equity grant rather than a market transaction.

How many JLL shares did Bridget Macaskill receive in the latest grant?

Bridget Macaskill received 635 shares of JONES LANG LASALLE INC Common Stock. These shares were granted as a stock award on June 1, 2026 at a price of $0.00 per share, increasing her direct ownership position in the company.

Was the JLL Form 4 transaction an open-market buy or a compensation grant?

The transaction was a compensation grant, not an open-market purchase. Bridget Macaskill received 635 shares of JONES LANG LASALLE INC Common Stock at a price of $0.00 per share, classified as a “Grant, award, or other acquisition” in the Form 4.

What transaction code is used for Bridget Macaskill’s JLL stock award?

The transaction uses code “A” for “Grant, award, or other acquisition.” This indicates Bridget Macaskill’s 635-share JONES LANG LASALLE INC Common Stock award on June 1, 2026 was a compensation-related grant rather than a purchase or sale in the open market.